We are live on !
Find out more
Nebula Research & Development Portfolio holdings
AUM
$1.17B
Turnover
43.96%
1-Year Est. Return
15.19%
This Fund
S&P 500
This Quarter Est. Return
+11.43%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.17B
AUM Growth
+$92.8M
(+8.6%)
Cap. Flow
+$15.3M
Cap. Flow % of AUM
Cap. Flow %
1.3%
Top 10 Holdings %
Top 10 Hldgs %
4.44%
Holding
1,192
New
267
Increased
346
Reduced
321
Closed
257
Avg Time Held
0.5
years
Top 10 Avg Time Held
0.1
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stride
LRN
|
+$5.17M |
| 2 |
FedEx
FDX
|
+$4.67M |
| 3 |
Restaurant Brands International
QSR
|
+$4.66M |
| 4 |
LKQ Corp
LKQ
|
+$4.61M |
| 5 |
American Airlines Group
AAL
|
+$4.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Parcel Service
UPS
|
+$4.82M |
| 2 |
Intercontinental Exchange
ICE
|
+$4.65M |
| 3 |
AutoZone
AZO
|
+$4.56M |
| 4 |
GoDaddy
GDDY
|
+$4.45M |
| 5 |
Agilent Technologies
A
|
+$4.12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.31% |
| 2 | Industrials | 15.93% |
| 3 | Consumer Discretionary | 15.09% |
| 4 | Healthcare | 11.66% |
| 5 | Financials | 11.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
901
Edgewise Therapeutics
EWTX
$4.22B
| $173K | 0.01% |
+13,219
| New | +$191K |
2025 Q2
0 quarters
|
|
902
DELISTED
Kennedy-Wilson Holdings
KW
| $172K | 0.01% |
+25,348
| New | +$169K |
2025 Q2
0 quarters
|
|
903
Ardmore Shipping
ASC
$857M
| $169K | 0.01% |
17,563
-5,027
| -22% | -$48.4K |
2024 Q3
3 quarters
|
|
904
Uranium Energy
UEC
$3.82B
| $168K | 0.01% |
+24,643
| New | +$138K |
2025 Q2
0 quarters
|
|
905
UroGen Pharma
URGN
$1.6B
| $162K | 0.01% |
+11,843
| New | +$114K |
2025 Q2
0 quarters
|
|
906
Playtika
PLTK
$755M
| $147K | 0.01% |
31,048
-70,079
| -69% | -$345K |
2023 Q3
7 quarters
|
|
907
Similarweb
SMWB
$771M
| $146K | 0.01% |
+18,647
| New | +$140K |
2025 Q2
0 quarters
|
|
908
DELISTED
Dynavax Technologies
DVAX
| $145K | 0.01% |
+14,599
| New | +$154K |
2025 Q2
0 quarters
|
|
909
VF Corp
VFC
$7.2B
| $141K | 0.01% |
12,003
-35,063
| -74% | -$435K |
2024 Q4
2 quarters
|
|
910
AngioDynamics
ANGO
$504M
| $140K | 0.01% |
14,116
-17,329
| -55% | -$170K |
2024 Q4
2 quarters
|
|
911
Prothena Corp
PRTA
$435M
| $139K | 0.01% |
+22,857
| New | +$172K |
2025 Q2
0 quarters
|
|
912
DELISTED
Udemy
UDMY
| $134K | 0.01% |
19,079
-32,114
| -63% | -$222K |
2024 Q4
2 quarters
|
|
913
Energy Fuels
UUUU
$2.04B
| $130K | 0.01% |
22,583
-21
| -0.1% | -$101 |
2024 Q3
3 quarters
|
|
914
EVgo
EVGO
$179M
| $123K | 0.01% |
33,572
-26,628
| -44% | -$91.2K |
2025 Q1
1 quarter
|
|
915
Oil States International
OIS
$579M
| $122K | 0.01% |
22,816
+2,474
| +12% | +$10.9K |
2024 Q1
5 quarters
|
|
916
Community Health Systems
CYH
$338M
| $116K | 0.01% |
+34,125
| New | +$110K |
2025 Q2
0 quarters
|
|
917
Petco
WOOF
$748M
| $115K | 0.01% |
40,707
+23,493
| +136% | +$73K |
2025 Q1
1 quarter
|
|
918
Navitas Semiconductor
NVTS
$2.23B
| $114K | 0.01% |
+17,428
| New | +$67.2K |
2025 Q2
0 quarters
|
|
|
PGRE
919
DELISTED
Paramount Group
PGRE
| $111K | 0.01% |
18,205
-117,776
| -87% | -$614K |
2023 Q4
6 quarters
|
|
920
Aurora
AUR
$8.81B
| $109K | 0.01% |
+20,784
| New | +$130K |
2025 Q2
0 quarters
|
|
921
TMC The Metals Company
TMC
$1.15B
| $107K | 0.01% |
+16,240
| New | +$62.3K |
2025 Q2
0 quarters
|
|
922
Xeris Biopharma Holdings
XERS
$1.95B
| $96.9K | 0.01% |
+20,751
| New | +$95.1K |
2025 Q2
0 quarters
|
|
923
Nano X Imaging
NNOX
$26M
| $96.1K | 0.01% |
18,590
-4,584
| -20% | -$23.4K |
2024 Q4
2 quarters
|
|
924
Health Catalyst
HCAT
$127M
| $95.4K | 0.01% |
25,305
-19,405
| -43% | -$76.3K |
2023 Q4
6 quarters
|
|
925
B&G Foods
BGS
$189M
| $90.6K | 0.01% |
21,424
-14,924
| -41% | -$77.9K |
2025 Q1
1 quarter
|
|
Similar funds
Nebula Research & Development's Q2 2025 Portfolio in Review
As of Q2 2025, Nebula Research & Development held 1,192 positions worth $1.17B, up 8.6% from $1.08B the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.
Nebula Research & Development's Q2 2025 filing shows 267 new, 346 increased, 321 reduced and 257 closed positions. Its largest new stake was Stride: 35,744 shares worth $5.19M. The largest sale was United Parcel Service, an estimated $4.82M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Industrials and Consumer Discretionary.
- Nebula Research & Development's largest Q2 2025 buy was Stride: 35,744 shares worth $5.19M.
- Nebula Research & Development added most to A.O. Smith in Q2 2025, an estimated $4.11M increase.
- Nebula Research & Development's biggest Q2 2025 reduction was Agilent Technologies, cutting an estimated $4.12M.
- Nebula Research & Development fully exited United Parcel Service in Q2 2025, selling an estimated $4.82M.
- Nebula Research & Development's ten largest holdings make up 4.4% of its $1.17B portfolio in Q2 2025.
- Nebula Research & Development opened 267 new positions and closed 257 in Q2 2025.
- Nebula Research & Development's portfolio value rose 8.6% quarter-over-quarter to $1.17B.
Based on Nebula Research & Development's 13F filing for Q2 2025, filed 14 Aug 2025.